ArticleBlood advances2020

Bridging therapy prior to axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma.

Chelsea C Pinnix et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.